Literature DB >> 24345382

Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.

Francesco Benedetti1, Roberta Riccaboni, Clara Locatelli, Sara Poletti, Sara Dallaspezia, Cristina Colombo.   

Abstract

BACKGROUND: One third of patients with bipolar disorder attempt suicide. Depression in bipolar disorder is associated with drug resistance. The efficacy of antidepressants on suicidality has been questioned. Total sleep deprivation and light therapy prompt a rapid and stable antidepressant response in bipolar disorder.
METHOD: We studied 143 consecutively admitted inpatients (December 2006-August 2012) with a major depressive episode in the course of bipolar disorder (DSM-IV criteria). Among the 141 study completers, 23% had a positive history of attempted suicide and 83% had a positive history of drug resistance. During 1 week, patients were administered 3 consecutive total sleep deprivation cycles (each composed of a period of 36 hours awake followed by recovery sleep) combined with bright light therapy in the morning for 2 weeks. At admission, patients who had been taking lithium continued it, and those who had not been taking lithium started it. Severity of depression was rated according to the Hamilton Depression Rating Scale (HDRS) (primary outcome measure) and Beck Depression Inventory (BDI).
RESULTS: Two patients switched polarity. Among the 141 who completed the treatment, 70% achieved a 50% reduction in HDRS score in 1 week, which persisted 1 month after in 55%. The amelioration involved an immediate and persistent decrease in suicide scores soon after the first total sleep deprivation cycle (F3,411 = 42.78, P < .00001). A positive history of suicide attempts was associated with worse early life stress and with worse suicide scores at baseline, but it did not influence response. Patients with current suicidal thinking or planning responded equally well (F3,42 = 20.70, P < .000001). Remarkably, however, nonresponders achieved a benefit, with significantly decreased final scores also including suicidality ratings (F3,120 = 6.55, P = .0004). Self-ratings showed the same pattern of change. Previous history of drug resistance did not hamper response. During the following month, 78 of 99 responders continued to stay well and were discharged from the hospital on lithium therapy alone.
CONCLUSIONS: The combination of total sleep deprivation, light therapy, and lithium is able to rapidly decrease depressive suicidality and prompt antidepressant response in drug-resistant major depression in the course of bipolar disorder. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24345382     DOI: 10.4088/JCP.13m08455

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  21 in total

1.  Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.

Authors:  Francesco Benedetti; Sara Poletti; Thomas A Hoogenboezem; Clara Locatelli; Oliver Ambrée; Harm de Wit; Annemarie J M Wijkhuijs; Elena Mazza; Chiara Bulgarelli; Benedetta Vai; Cristina Colombo; Enrico Smeraldi; Volker Arolt; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

Review 2.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

3.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

4.  Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study.

Authors:  Gregory L Sahlem; Benjamin Kalivas; James B Fox; Kayla Lamb; Amanda Roper; Emily N Williams; Nolan R Williams; Jeffrey E Korte; Zachary D Zuschlag; Salim El Sabbagh; Constance Guille; Kelly S Barth; Thomas W Uhde; Mark S George; E Baron Short
Journal:  J Psychiatr Res       Date:  2014-09-03       Impact factor: 4.791

Review 5.  Circadian Rhythm Dysregulation in Bipolar Spectrum Disorders.

Authors:  Lauren B Alloy; Tommy H Ng; Madison K Titone; Elaine M Boland
Journal:  Curr Psychiatry Rep       Date:  2017-04       Impact factor: 5.285

6.  Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis.

Authors:  Shengjun Wang; Zhigang Zhang; Li Yao; Nannan Ding; Lingjie Jiang; Yuchen Wu
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 7.  Clocking in: chronobiology in rheumatoid arthritis.

Authors:  Frank Buttgereit; Josef S Smolen; Andrew N Coogan; Christian Cajochen
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

8.  Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders.

Authors:  Ausaf A Bari; Charles B Mikell; Aviva Abosch; Sharona Ben-Haim; Robert J Buchanan; Allen W Burton; Stephen Carcieri; G Rees Cosgrove; Pierre-Francois D'Haese; Zafiris Jeffrey Daskalakis; Emad N Eskandar; Jason L Gerrard; Wayne K Goodman; Benjamin David Greenberg; Robert E Gross; Clement Hamani; Zelma H T Kiss; Peter Konrad; Brian H Kopell; Lothar Krinke; Jean-Philippe Langevin; Andres M Lozano; Donald Malone; Helen S Mayberg; Jonathan P Miller; Parag G Patil; DeLea Peichel; Erika A Petersen; Ali R Rezai; R Mark Richardson; Patricio Riva-Posse; Tejas Sankar; Jason M Schwalb; Helen Blair Simpson; Konstantin Slavin; Paul H Stypulkowski; Tor Tosteson; Peter Warnke; Jon T Willie; Kareem A Zaghloul; Joseph S Neimat; Nader Pouratian; Sameer A Sheth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-25       Impact factor: 10.154

9.  Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

Authors:  Elizabeth D Ballard; Jennifer L Vande Voort; Rebecca A Bernert; David A Luckenbaugh; Erica M Richards; Mark J Niciu; Maura L Furey; Wallace C Duncan; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

10.  Meta-analysis of sleep deprivation in the acute treatment of bipolar depression.

Authors:  John F Gottlieb; Namni Goel; Shenghao Chen; Michael A Young
Journal:  Acta Psychiatr Scand       Date:  2020-12-26       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.